ICON PLC (ICLR) stock
ICLRNasdaqServices-Commercial Physical & Biological Research
$194.65−5.86 (-2.92%)
Close on Nov 13, 2026Market cap $14.90BP/E 33.5Yield –
ICON total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
ICON's total debt was $3.38B at Sep 30, 2026. For fiscal 2025 it was $2.87B, down 15.4% from the year before. The highest annual figure on record is $5.38B in fiscal 2021.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.87B | -15.4% |
| FY2024 | Dec 31, 2024 | $3.40B | -7.3% |
| FY2023 | Dec 31, 2023 | $3.67B | -20.3% |
| FY2022 | Dec 31, 2022 | $4.60B | -14.5% |
| FY2021 | Dec 31, 2021 | $5.38B | +1444.2% |
| FY2020 | Dec 31, 2020 | $348.48M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.38B | +17.4% |
| Q2 FY2026 | Jun 30, 2026 | $2.11B | -37.6% |
| Q1 FY2026 | Mar 31, 2026 | $2.87B | -15.4% |
| Q4 FY2025 | Dec 31, 2025 | $2.87B | -15.4% |
| Q3 FY2025 | Sep 30, 2025 | $2.88B | -15.4% |
| Q2 FY2025 | Jun 30, 2025 | $3.38B | -0.7% |
| Q1 FY2025 | Mar 31, 2025 | $3.39B | -0.9% |
| Q4 FY2024 | Dec 31, 2024 | $3.40B | -7.3% |
| Q3 FY2024 | Sep 30, 2024 | $3.40B | -13.0% |
| Q2 FY2024 | Jun 30, 2024 | $3.41B | -19.0% |
| Q1 FY2024 | Mar 31, 2024 | $3.42B | -21.4% |
| Q4 FY2023 | Dec 31, 2023 | $3.67B | -20.3% |
| Q3 FY2023 | Sep 30, 2023 | $3.91B | -18.4% |
| Q2 FY2023 | Jun 30, 2023 | $4.21B | -15.7% |
| Q1 FY2023 | Mar 31, 2023 | $4.35B | -14.4% |
| Q4 FY2022 | Dec 31, 2022 | $4.60B | -14.5% |
| Q3 FY2022 | Sep 30, 2022 | $4.79B | -20.1% |
| Q2 FY2022 | Jun 30, 2022 | $4.99B | +1332.1% |
| Q1 FY2022 | Mar 31, 2022 | $5.09B | – |
| Q4 FY2021 | Dec 31, 2021 | $5.38B | – |
| Q3 FY2021 | Sep 30, 2021 | $6.00B | – |
| Q4 FY2020 | Dec 31, 2020 | $348.48M | – |
See a number that looks wrong?